As a proof-of-concept, low HHLA2-expressing OVCAR-3 and PEO1 cells were selected to construct HHLA2-overexpressing cell lines to investigate the intrinsic biological function of HHLA2 in ovarian cancer (Fig. 6b–d). Here, HHLA2 is linked to ovarian cancer.